Aggregate data underlying the findings are available in the body of the paper. All original person-specific data cannot be shared publicly due to ethical restrictions but are available upon request to those who meet the criteria for access to confidential data. Please contact Dr Rita Krishnamurthi, National Institute for Stroke & Applied Neurosciences, AUT University to request access.

Introduction {#sec005}
============

The burden of stroke is large and increasing worldwide, with notable ethnic/racial disparities.\[[@pone.0134609.ref001]--[@pone.0134609.ref007]\] Effective primary stroke prevention strategies are therefore critical in ageing populations\[[@pone.0134609.ref001],[@pone.0134609.ref008]\] and where there is increasing numbers of people surviving with stroke-related disability and ongoing risk.\[[@pone.0134609.ref009]\] However, because of the considerable challenges to determining temporal trends in incidence and outcome of stroke, there is limited information on the impact of declines (or increases) in rates and case fatality in whole populations. This leaves uncertainties regarding the impact of public health policies and improvements in health service delivery for this important disease.\[[@pone.0134609.ref010]--[@pone.0134609.ref013]\]

As a large proportion of the burden of stroke is borne outside the hospital sector, it is crucial that incident cases are ascertained and studied in a population-wide context.\[[@pone.0134609.ref010],[@pone.0134609.ref011],[@pone.0134609.ref013]\] Over the last two decades new primary and secondary preventative strategies have been implemented but the effect of the strategies on stroke burden have not been reliably assessed.\[[@pone.0134609.ref014]\] Accurate population-based data on population trends in stroke incidence and risk factors reflect the success or otherwise of prevention strategies, while case-fatality and mortality trends reflect management and natural history of stroke. All these indices are crucial for evidence-based planning and resource allocation for stroke services and preventive strategies. Yet population-based stroke incidence studies are complex,\[[@pone.0134609.ref010],[@pone.0134609.ref013]\] and are limited in number when compared to those using hospital-based registers, mortality data, or studies limited to certain age groups. To address this gap, we used population-based data from the four Auckland Regional Community Stroke (ARCOS I---IV) studies (1981--1982, 1991--1992, 2002--2003 and 2011--2012) to determine 30-year trends in stroke incidence, case-fatality and mortality in the four major ethnic groups (NZ European, Asian, Māori and Pacific Islanders) in Auckland, New Zealand (NZ).

Materials and Methods {#sec006}
=====================

Study populations, case ascertainment and diagnostic criteria {#sec007}
-------------------------------------------------------------

The study population and methods of case ascertainment in the four ARCOS studies are described in detail elsewhere.\[[@pone.0134609.ref012],[@pone.0134609.ref015]--[@pone.0134609.ref018]\] In brief, these studies utilised harmonised population-based registers of all new cases of stroke in the greater Auckland region over consistent 12 month calendar periods (total resident population aged ≥15 grew from 596,580 in 1981--1982 to 1,119,192 in 2011--2012). Multiple overlapping methods of case ascertainment, and standard WHO clinical diagnostic criteria for stroke were utilised.\[[@pone.0134609.ref019]\] For the 1991--1992 ARCOS study, all hospital-managed stroke events in the region, and a cluster survey of 25% of all primary care general practitioners (GPs) records, were used to estimate the total number of non-hospitalised, non-fatal stroke events.\[[@pone.0134609.ref012]\] For the 1981--1982 ARCOS study, a cluster sample of 50% of all registered GPs was used to identify a representative sample of stroke events in the study population. All deceased cases were identified through hospital admissions and discharge reports, systematic searches of post-mortem reports and death certificates in national registries. Data for fatal non-hospitalised SAH cases were collected from medical records only. In the two most recent studies (2002--2003 and 2011--2012)\[[@pone.0134609.ref012],[@pone.0134609.ref015]\] no cluster sampling was used and instead the whole study population was monitored for new stroke events. To ensure a complete prospective case-ascertainment in 2002--2003 and 2011--2012 studies we undertook daily searches of hospital presentation data, where a diagnosis suggesting stroke or transient ischaemic attack (TIA) was recorded for all public hospitals and emergency departments, CT/MRI records and hospital discharge registers; weekly checks of all private hospitals, rest homes, and community health services (general practices, hospital outpatient clinics and rehabilitation centres); quarterly checks of coroner/autopsy records, death certificates (from Registrar of Births, Deaths and Marriages) to identify people who had died with any mention of stroke, and NZ Health Information Service data of all fatal and non-fatal stroke/TIA cases in the study population. In 2002--2003 and 2011--2012 studies strokes were subdivided into pathological types (ischaemic stroke \[IS\], primary intracerebral haemorrhage \[PICH\], subarachnoid haemorrhage \[SAH\]) according to neuroimaging (CT, MRI, or necropsy) findings. SAH was defined as "an abrupt onset of a severe headache and/or impaired consciousness or focal neurological signs associated with at least one of the following findings: uniform blood staining of the cerebrospinal fluid; CT evidence of blood in the subarachnoid space; cerebral angiographic identification of an aneurysm or arteriovenous malformation, or identification of SAH at surgery or at autopsy. This definition excludes PICH with extension into the subarachnoid space and subarachnoid bleeding due to trauma, neoplasms, or infections".\[[@pone.0134609.ref020]\] All new stroke cases, including suspected strokes, were ascertained by study researchers across all four studies. Consistent diagnostic criteria were used across all studies to allow valid comparisons. Cases without imaging or pathological necropsy confirmation of stroke type were classified as stroke of undetermined type (undetermined). Cardiovascular risk factors and medication use were ascertained via medical records across all studies. All study participants were followed up for 1 year for fatal/non-fatal outcomes. Ethnicity was identified by self-report across all four studies. Regional Ethics Committees approved all four studies.

Statistical analyses {#sec008}
--------------------

For the 1981--1982 and 2002--2003 ARCOS studies participants selected one self-identified ethnicity to be used for the analyses. For the 1991--1992 and 2011--2012 ARCOS studies, multiple self-identified ethnicities were recorded and ethnicity was prioritised corresponding to the allocation process and using NZ census definitions for Māori, Pacific, Asian/other ("other" included ethnic groups such as other European, Middle Eastern, Latin American and African ethnicities) and NZ Europeans as per the NZ Census.\[[@pone.0134609.ref021]\] When multiple ethnicities were self-identified, ethnicity was prioritized as a single ethnic group for the purposes of analysis in the following order: Māori, Pacific, Asian/other, NZ European. For example if a person self-identified as NZ European and Māori, they were classified as Māori, and if they self-identified as Pacific and Chinese they were classified as Pacific. Ethnicity information was not available for 2 of the ARCOS 2011--2012 study participants and 46 of the ARCOS 2002--2003 study participants, who were excluded from the ethnicity analyses. Age, sex and ethnic structure of the corresponding Auckland census data were used as the denominator in calculating incidence.

Crude annual age-, sex-, and ethnic-specific stroke incidence (first-ever-in-a-lifetime events) and attack rates (all events, including recurrent strokes), 28-day case fatality (proportion \[%\] of people with stroke who died within 28 days of stroke onset among the total number of people with incident stroke) and mortality rates (number of people with incident stroke who died in the study population over one-year follow-up period \[nominator\] divided by the study population at risk \[denominator\]), with 95% confidence intervals (CI) per 100,000 people were calculated assuming a Poisson distribution. Sampling procedure differences between ARCOS 1981--1982 and 1991--1992 studies were taken into account when computing CI and standard error (SE) of all estimated rates, as described elsewhere.\[[@pone.0134609.ref012]\] Standardised rates were calculated using the direct method and age-standardised to WHO 'World' standard population.\[[@pone.0134609.ref022]\] Rate ratios (RR) were calculated to evaluate differences in age-adjusted rates between the 1981--1982 and 2011--2012 study periods, and the Wald statistic test of heterogeneity across age groups were performed.\[[@pone.0134609.ref012]\] For categorical variables, the Cochrane-Armitage test was used to assess whether there was evidence of a statistically significant trend. For continuous variables, analysis of variance or the Kruskal-Wallis test was used.

Completeness of case ascertainment based on the sources of notification was determined using capture-recapture techniques.\[[@pone.0134609.ref023]\] This involved conducting log-linear modelling assuming a Poisson distribution (unadjusted for sample procedures),\[[@pone.0134609.ref024]\] and used the four main sources of notification: hospital, general practitioner, death certificate and other sources. The final model with the least deviance, (deviance is an indicator of 'goodness of fit' and a lower deviance suggests a better fitting model), for all studies included the main effects of the four sources and the 3-way interaction between hospital, general practitioner and death certificate. A Bonferroni-corrected threshold of p = 0.00013 (based on 380 tests conducted 0.05/380) was used to indicate statistical significance after adjusting for multiple testing.

To compare our findings with similar population-based studies carried out in other countries we searched Medline with the terms"stroke", "epidemiology", "incidence", "ethnic/racial", "trend(s)", and "population or community based" for population-based studies of stroke carried out between 1980 and 2014 and published in English. Only population-based studies from high-income countries that reported age-specific raw numbers of first-ever-in-a-lifetime strokes (numerator and populations at risk (denominator) sufficient to calculate incidence rates age-standardised to WHO 'World' standard population\[[@pone.0134609.ref022]\] were included in the analysis. We also compared trends in stroke incidence and mortality rates from our series of Auckland Regional Community Stroke (ARCOS) studies (1981--1982, 1991--1992, 2002--2003, 2011--2012) with those found in the Global Burden of Disease (GBD) 2010 study.\[[@pone.0134609.ref001],[@pone.0134609.ref025]\]

Results and Discussion {#sec009}
======================

Results {#sec010}
-------

There were 5400 new stroke patients (47% men) registered across the four studies (Tables [1](#pone.0134609.t001){ref-type="table"} and [2](#pone.0134609.t002){ref-type="table"}). Over the 30-year study period, the proportion of patients presenting with recurrent strokes decreased by 2.95% (95% CI 0.60%-5.83%) from 24.3% to 21.4%. The mean age of individuals with stroke increased (on average by 3 years) across ethnic groups, except for Asian/other ethnic group where age decreased by 4.6 years (95% CI 3.8--14.1). However, the 15-year gap between in the mean age at stroke onset in Māori and Pacific (youngest age group) compared with the mean age of stroke in NZ European (oldest age group) persisted over the 30 years. Although NZ European patients constituted the largest proportion of strokes, their proportional frequency reduced by 23% (95% CI 21.0%-26.0%) over the same period, while the proportional frequency of stroke patients from all other ethnic groups increased, with the largest increase being 8-fold for the Asian/other ethnic groups ([Table 1](#pone.0134609.t001){ref-type="table"}).

10.1371/journal.pone.0134609.t001

###### Baseline characteristics and 28-day outcome of stroke events in each ARCOS register.

![](pone.0134609.t001){#pone.0134609.t001g}

                                                                                                                              1981--1982       1991--1992                                                                               2002--2003       2011--2012      *P* for trend[^§§^](#t001fn001){ref-type="table-fn"}
  --------------------------------------------------------------------------------------------------------------------------- ---------------- ---------------------------------------------------------------------------------------- ---------------- --------------- ----------------------------------------------------------------------------------------
  **Demographics**                                                                                                                                                                                                                                                       
   Male                                                                                                                       662 (48.7)       817 (46.4)                                                                               892 (46.0)       1012 (48.3)     0.977
   Age, mean (±SD), years[\*\*\*](#t001fn004){ref-type="table-fn"}                                                                                                                                                                                                       
    NZ/European                                                                                                               72.2 (12.8)      73.5 (12.1)                                                                              75.6 (12.5)      75.3 (13.4)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     56.7 (14.2)      55.0 (16.1)                                                                              60.7 (14.3)      59.6 (15.5)     0.04
    Pacific                                                                                                                   55.8 (9.0)       59.7 (15.0)                                                                              64.5 (13.6)      61.6 (14.9)     0.002
    Asian/other                                                                                                               72.1 (12.8)      65.6 (13.2)                                                                              65.9 (13.9)      67.5 (13.3)     0.199
    Overall                                                                                                                   71.2 (13.3)      71.6 (13.5)                                                                              73.0 (13.8)      71.6 (14.9)     0.001
   Ethnicity                                                                                                                                                                                                                                                             
    NZ/European                                                                                                               1248 (91.8)      1532 (87.0)                                                                              1431 (75.6)      1434 (68.5)     \<0.0001[\*\*](#t001fn003){ref-type="table-fn"} [^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     60 (4.4)         82 (4.7)                                                                                 102 (5.4)        138 (6.6)       
    Pacific                                                                                                                   32 (2.4)         111 (6.3)                                                                                197 (10.4)       270 (12.9)      
    Asian/other                                                                                                               20 (1.5)         36 (2.0)                                                                                 162 (8.6)        252 (12.0)      
  **Source of notification**                                                                                                                   \<0.0001[\*\*](#t001fn003){ref-type="table-fn"} [^§^](#t001fn006){ref-type="table-fn"}                                    
   Hospital                                                                                                                   1082 (80.0)      1092 (62.0)                                                                              1361 (70.2)      1733 (82.7)     
   General practitioner                                                                                                       30 (2.2)         368 (20.9)                                                                               117 (6.0)        2 (0.1)         
   Death certificate                                                                                                          104 (7.7)        161 (9.1)                                                                                95 (4.9)         15 (0.7)        
   Other sources                                                                                                              136 (10.1)       140 (8.0)                                                                                365 (18.8)       346 (16.5)      
  **Premorbid risk factors (from medical notes)**                                                                                                                                                                                                                        
   Current smoking                                                                                                                                                                                                                                                       
    NZ/European                                                                                                               330 (26.7)       330 (21.7)                                                                               162 (12.6)       178 (12.8)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     32 (53.3)        41 (50.6)                                                                                35 (38.9)        55 (40.4)       0.159
    Pacific                                                                                                                   12 (37.5)        31 (28.7)                                                                                23 (13.1)        65 (24.4)       0.001
    Asian/other                                                                                                               0                9 (25.0)                                                                                 15 (10.3)        23 (9.3)        0.013
    Overall                                                                                                                   374 (27.7)       411 (23.5)                                                                               241 (14.0)       322 (15.8)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   High blood pressure                                                                                                                                                                                                                                                   
    NZ/European                                                                                                               632 (51.1)       802 (52.7)                                                                               783 (57.7)       947 (66.0)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     38 (63.3)        41 (52.6)                                                                                63 (62.4)        85 (61.6)       0.690
    Pacific                                                                                                                   22 (68.8)        49 (45.0)                                                                                124 (65.6)       178 (65.9)      0.022
    Asian/other                                                                                                               8 (40.0)         18 (50.0)                                                                                88 (58.7)        184 (73.0)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Overall                                                                                                                   700 (51.5)       910 (52.1)                                                                               1079 (59.0)      1394 (66.5)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Myocardial infarction                                                                                                                                                                                                                                                 
    NZ/European                                                                                                               146 (11.8)       273 (17.9)                                                                               190 (13.5)       401 (28.0)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     8 (13.8)         9 (11.4)                                                                                 12 (11.9)        25 (18.1)       0.266
    Pacific                                                                                                                   2 (6.7)          3 (2.8)                                                                                  15 (7.9)         34 (12.6)       0.004
    Asian/other                                                                                                               0                3 (8.3)                                                                                  17 (11.0)        47 (18.7)       0.003
    Overall                                                                                                                   156 (11.5)       288 (16.5)                                                                               240 (12.7)       507 (24.2)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Previous stroke                                                                                                                                                                                                                                                       
    NZ/European                                                                                                               314 (25.3)       404 (26.4)                                                                               361 (25.5)       308 (21.5)      0.015
    Māori                                                                                                                     14 (23.3)        21 (25.6)                                                                                12 (11.9)        21 (15.2)       0.041
    Pacific                                                                                                                   2 (6.3)          25 (22.5)                                                                                54 (27.8)        62 (23.2)       0.234
    Asian/other                                                                                                               0                6 (16.7)                                                                                 36 (23.1)        56 (22.3)       0.067
    Overall                                                                                                                   330 (24.3)       456 (25.9)                                                                               477 (25.1)       448 (21.4)      0.016
   Diabetes mellitus                                                                                                                                                                                                                                                     
    NZ/European                                                                                                               98 (7.9)         193 (12.6)                                                                               179 (12.7)       236 (16.5)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     20 (33.3)        19 (24.4)                                                                                35 (34.7)        41 (29.7)       0.975
    Pacific                                                                                                                   12 (46.2)        16 (15.0)                                                                                69 (36.1)        117 (43.3)      0.0003
    Asian/other                                                                                                               4 (20.0)         8 (22.2)                                                                                 40 (26.1)        77 (30.6)       0.131
    Overall                                                                                                                   134 (10.0)       236 (13.6)                                                                               329 (17.4)       471 (22.5)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Atrial fibrillation                                                                                                                                                                                                                                                   
    NZ/European                                                                                                               NA               NA                                                                                       328 (23.7)       460 (32.1)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     NA               NA                                                                                       29 (28.7)        42 (30.4)       0.774
    Pacific                                                                                                                   NA               NA                                                                                       41 (21.5)        62 (23.0)       0.704
    Asian/other                                                                                                               NA               NA                                                                                       18 (11.9)        47 (18.7)       0.075
    Overall                                                                                                                   NA               NA                                                                                       416 (22.0)       611 (29.2)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **Premorbid medication**                                                                                                                                                                                                                                               
   Blood pressure lowering meds                                                                                                                                                                                                                                          
    NZ/European                                                                                                               428 (35.2)       539 (35.2)                                                                               712 (50.8)       910 (63.5)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     26 (43.3)        21 (25.6)                                                                                49 (48.5)        79 (57.2)       0.001
    Pacific                                                                                                                   16 (50.0)        30 (27.0)                                                                                94 (49.2)        168 (62.2)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               6 (30.0)         14 (38.9)                                                                                73 (47.1)        163 (64.7)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Overall                                                                                                                   476 (35.0)       604 (34.3)                                                                               942 (49.0)       1321 (63.0)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Antiplatelet agents                                                                                                                                                                                                                                                   
    NZ/European                                                                                                               314 (27.4)       358 (23.4)                                                                               665 (48.2)       707 (49.3)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     12 (21.4)        7 (8.5)                                                                                  29 (29.6)        60 (43.5)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Pacific                                                                                                                   8 (28.6)         14 (12.6)                                                                                63 (33.5)        115 (42.6)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               4 (25.0)         8 (22.2)                                                                                 56 (36.6)        117 (46.4)      0.001
    Overall                                                                                                                   338 (24.8)       387 (22.0)                                                                               832 (42.9)       999 (47.7)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Anticoagulants                                                                                                                                                                                                                                                        
    NZ/European                                                                                                               NA               33 (2.2)                                                                                 137 (9.9)        117 (8.2)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     NA               10 (12.2)                                                                                12 (12.2)        7 (5.1)         0.052
    Pacific                                                                                                                   NA               2 (1.8)                                                                                  27 (14.1)        24 (8.9)        0.172
    Asian/other                                                                                                               NA               0                                                                                        8 (5.2)          14 (5.6)        0.269
    Overall                                                                                                                   NA               45 (2.6)                                                                                 185 (9.9)        162 (7.7)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Lipid lowering drugs                                                                                                                                                                                                                                                  
    NZ/European                                                                                                               NA               NA                                                                                       213 (15.6)       567 (39.5)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     NA               NA                                                                                       13 (13.4)        58 (42.0)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Pacific                                                                                                                   NA               NA                                                                                       19 (10.4)        117 (43.3)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               NA               NA                                                                                       27 (18.0)        116 (46.0)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Overall                                                                                                                   NA               NA                                                                                       272 (14.4)       858 (40.9)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **Management**                                                                                                                                                                                                                                                         
   Admission to hospital within 28 days of stroke onset                                                                                                                                                                                                                  
    NZ/European                                                                                                               768 (61.5)       1088 (71.0)                                                                              1283 (89.7)      1291 (90.0)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     46 (76.7)        73 (89.0)                                                                                99 (97.1)        124 (89.9)      0.021
    Pacific                                                                                                                   22 (68.8)        87 (78.4)                                                                                188 (95.4)       259 (95.9)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               14 (70.0)        28 (77.8)                                                                                157 (96.9)       230 (91.3)      0.010
    Overall                                                                                                                   850 (62.5)       1276 (72.5)                                                                              1727 (91.3)      1904 (90.9)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Admission to acute stroke unit                                                                                                                                                                                                                                        
    NZ/European                                                                                                               NA               NA                                                                                       140 (9.8)        709 (50.8)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     NA               NA                                                                                       32 (31.4)        61 (46.2)       0.021
    Pacific                                                                                                                   NA               NA                                                                                       39 (19.8)        140 (54.1)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               NA               NA                                                                                       24 (14.8)        131 (54.1)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Overall                                                                                                                   NA               NA                                                                                       238 (12.3)       1041 (51.3)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
   Neuroimaging, CT/MRI                                                                                                                                                                                                                                                  
    NZ/European                                                                                                               134 (18.9)       429 (38.9)                                                                               1236 (86.4)      1389 (97.1)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     18 (50.0)        50 (67.6)                                                                                99 (97.1)        134 (97.8)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Pacific                                                                                                                   6 (42.9)         50 (57.5)                                                                                180 (91.4)       261 (97.4)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               4 (40.0)         12 (42.9)                                                                                153 (95.0)       244 (96.8)      \<0.0001^±^
    Overall                                                                                                                   162 (11.9)       541 (41.9)                                                                               1694 (87.6)      2030 (97.2)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **28-day case-fatality**                                                                                                                                                                                                                                               
    NZ/European                                                                                                               408 (32.7)       362 (23.6)                                                                               304 (21.2)       279 (19.5)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     18 (30.0)        20 (24.4)                                                                                24 (23.5)        23 (16.7)       0.033
    Pacific                                                                                                                   14 (43.8)        32 (28.8)                                                                                39 (19.8)        43 (15.9)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               10 (50.0)        7 (19.4)                                                                                 24 (14.8)        47 (18.7)       0.056
    Overall                                                                                                                   450 (33.1)       421 (23.9)                                                                               407 (20.7)       393 (18.8)      \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **Pathological type of stroke**                                                                                                                                                                                                                                        
    Ischaemic stroke                                                                                                          NA               NA                                                                                       1380 (71.2)      1694 (80.8)     \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Primary intracerebral haemorrhage                                                                                         NA               NA                                                                                       236 (12.2)       275 (13.1)      0.368
    Subarachnoid haemorrhage                                                                                                  90 (6.6)         76 (4.3)                                                                                 96 (5.0)         87 (4.2)        0.008
    Undetermined                                                                                                              NA               NA                                                                                       226 (11.7)       40 (1.9)        \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **Time from stroke onset to study assessment (days), median (interquartile range)** [\*](#t001fn002){ref-type="table-fn"}                                                                                                                                              
    NZ/European                                                                                                               19 (6--38)       17 (7--64)                                                                               27 (5--129)      6 (3--27)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Māori                                                                                                                     31 (5--42)       18 (6--77)                                                                               25 (4--112)      7 (3--91)       0.097
    Pacific                                                                                                                   21 (9--58)       13 (6--57)                                                                               15 (4--132)      5 (2--27)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Asian/other                                                                                                               29 (7--44)       12 (5--67)                                                                               18 (5--115)      6 (3--28)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
    Overall                                                                                                                   20 (6--38)       16 (6--64)                                                                               27 (5--139)      6 (3--29)       \<0.0001[^§^](#t001fn006){ref-type="table-fn"}
  **Capture-recapture, missing** [\*\*\*\*](#t001fn005){ref-type="table-fn"}                                                  131/677 (19.3)   185/1449 (12.8)                                                                          144/1938 (7.4)   30/2096 (1.4)   \<0.0001[^§^](#t001fn006){ref-type="table-fn"}

^§§^ *P* value calculated using Cochrane-Armitage trend test;

\*P value calculated using Kruskal-Wallis test;

\*\*P value calculated using Chi-squared test,

\*\*\*P value calculated using analysis of variance test,

\*\*\*\* Using log-linear model containing main effects and interaction for hospital x general practitioner x death certificate. Information about medication was collected in a month prior to stroke.

^§^ *P*-values that remained significant after applying Bonferroni-correction to adjust for multiple testing for 380 tests (19 variables \[age, source of notification, high blood pressure, myocardial infarction, previous stroke, diabetes mellitus, atrial fibrillation, current smoking, blood pressure lowering medication, antiplatelet agents, anticoagulants, lipid lowering drugs, admission to hospital within 28 days of stroke onset, admission to acute stroke unit, neuroimaging/CT/MRI, 28-day case fatality, pathological type of stroke, time from stroke onset, capture-recapture) by 5 ethnic grouping (New Zealand European, Maori, Pacific, Asian/Other and Overall) by four points (ARCOS I 1981/1982, ARCOS II 1991/1992, ARCOS III 2002/2003, ARCOS IV 2011/2012), giving a Bonferroni-corrected p-value threshold of = 0.05/380 tests = 0.00013

10.1371/journal.pone.0134609.t002

###### Crude, age-specific and age-standardised annual stroke incidence rates (first-ever strokes) per 100,000 people-years in Auckland, New Zealand across four study periods (1981--1982, 1991--1992, 2002--2003 and 2011--2012) by sex and ethnicity.

![](pone.0134609.t002){#pone.0134609.t002g}

  Age, sex and ethnicity group                                  1981--1982   1991--1992   2002--2003             2011--2012   P for                                                                                                   
  ------------------------------------------------------------- ------------ ------------ ---------------------- ------------ ------- -------------------- -------- ------ -------------------- --------- ------ -------------------- --------------
  **Total**                                                                                                                                                                                                                           
  15--64[\*](#t002fn002){ref-type="table-fn"}                   518112       286          55 (46; 64)            624828       347     56 (48; 63)          788106   391    50 (45; 55)          956037    528    55 (51; 60)          
  65--74                                                        49812        260          522 (432; 612)         56388        373     661 (564; 759)       59454    336    565 (505; 626)       95190     363    381 (342; 421)       
  75--84                                                        22965        350          1524 (1298; 1750)      31701        412     1300 (1139; 1460)    37815    438    1158 (1050; 1267)    48387     442    913 (828; 999)       
  85+                                                           5691         134          2355 (1791; 2918)      8541         173     2026 (1684; 2367)    12507    258    2063 (1811; 2315)    19578     310    1583 (1407; 1760)    
  Total                                                         596580       1030         173 (158; 188)         721458       1305    181 (168; 194)       897882   1423   158 (150; 167)       1119192   1643   147 (140; 154)       \<0.0001
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **156 (143; 170)**                          **156 (145; 167)**                   **139 (132; 147)**                    **119 (114; 125)**   \<0.0001
  **Male**                                                                                                                                                                                                                            
  15--64[\*](#t002fn002){ref-type="table-fn"}                   256500       164          64 (50; 78)            308997       197     64 (52; 75)          380139   216    57 (49; 64)          461418    264    57 (50; 64)          
  65--74                                                        22251        158          710 (553; 867)         25452        201     790 (628; 951)       28173    198    703 (605; 801)       45678     211    462 (400; 524)       
  75--84                                                        8742         150          1716 (1328; 2104)      11946        155     1298 (1038; 1557)    15210    189    1243 (1065; 1420)    21759     223    1025 (890; 1159)     
  85+                                                           1509         38           2518 (1386; 3651)      2421         34      1404 (932; 1876)     3633     64     1762 (1330; 2193)    6807      93     1366 (1089; 1644)    
  Total                                                         289002       510          176 (155; 198)         348816       587     168 (150; 186)       427155   667    156 (144; 168)       535662    791    148 (137; 158)       0.0006
  **Standardised**                                                                        **184 (163; 209)**                          **167 (150; 185)**                   **156 (144; 168)**                    **129 (120; 138)**   **\<0.0001**
  **Female**                                                                                                                                                                                                                          
  15--64[\*](#t002fn002){ref-type="table-fn"}                   261612       122          47 (35; 58)            315831       150     47 (38; 57)          407967   175    43 (37; 49)          494631    264    53 (47; 60)          
  65--74                                                        27561        102          370 (269; 472)         30936        172     556 (437; 675)       31281    138    441 (368; 515)       49509     152    307 (258; 356)       
  75--84                                                        14223        200          1406 (1131; 1682)      19755        257     1301 (1096; 1505)    22605    249    1102 (965; 1238)     26634     219    822 (713; 931)       
  85+                                                           4182         96           2296 (1646; 2945)      6120         139     2271 (1833; 2709)    8874     194    2186 (1879; 2494)    12771     217    1699 (1473; 1925)    
  Total                                                         307578       520          169 (149; 190)         372642       718     193 (175; 211)       470727   756    161 (149; 172)       583545    852    146 (136; 156)       \<0.0001
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **133 (118; 151)**                          **143 (130; 158)**                   **124 (115; 133)**                    **110 (103; 119)**   **\<0.0001**
  **European**                                                                                                                                                                                                                        
  15--64[\*](#t002fn002){ref-type="table-fn"}                   422202       224          53 (43; 63)            459267       233     51 (42; 59)          501426   222    44 (38; 50)          450759    252    56 (49; 63)          
  65--74                                                        47481        238          501 (411; 591)         52125        341     654 (552; 756)       48633    219    450 (391; 510)       64806     239    369 (322; 416)       
  75--84                                                        22209        342          1540 (1309; 1771)      30303        387     1277 (1114; 1441)    34332    378    1101 (990; 1212)     35916     354    986 (883; 1088)      
  85+                                                           5577         130          2331 (1764; 2898)      8253         167     2024 (1675; 2372)    11790    233    1976 (1722; 2230)    16776     279    1663 (1468; 1858)    
  Total                                                         497469       934          188 (171; 205)         549948       1128    205 (189; 221)       596181   1052   176 (166; 187)       568257    1124   198 (186; 209)       0.992
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **153 (139--167)**                          **150 (139; 163)**                   **124 (116; 132)**                    **122 (114; 130)**   **\<0.0001**
  **Māori**                                                                                                                                                                                                                           
  15--64[\*](#t002fn002){ref-type="table-fn"}                   52179        36           69 (37; 101)           63762        48      75 (49; 101)         77742    53     68 (50; 87)          88470     74     84 (65; 103)         
  65--74                                                        1266         6            474 (-62; 1010)        1344         3       223 (-29; 476)       2292     22     960 (559; 1361)      4452      22     494 (288; 701)       
  75--84                                                        336          4            1190 (-459; 2840)      429          8       1865 (573; 3157)     654      10     1529 (581; 2477)     1572      19     1209 (665; 1752)     
  85+                                                           51           0            0                      72           2       2778 (-1072; 6628)   144      4      2778 (56; 5500)      243       2      823 (-318; 1964)     
  Total                                                         53832        46           85 (51; 120)           65607        61      93 (65; 121)         80832    89     110 (87; 133)        94737     117    123 (101; 146)       0.014
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **134 (78; 229)**                           **168 (116; 241)**                   **202 (157; 259)**                    **156 (128; 189)**   **0.757**
  **Pacific**                                                                                                                                                                                                                         
  15--64[\*](#t002fn002){ref-type="table-fn"}                   33672        20           59 (23; 96)            64506        51      79 (55; 103)         89724    66     74 (56; 91)          107688    126    117 (97; 137)        
  65--74                                                        741          10           1350 (167; 2532)       2025         21      1037 (481; 1593)     3840     47     1224 (874; 1574)     6417      43     670 (470; 870)       
  75--84                                                        213          0            0                      597          12      2010 (402; 3618)     1392     24     1724 (1034; 2414)    2679      29     1082 (689; 1476)     
  85+                                                           33           0            0                      108          2       1852 (-715; 4418)    246      3      1220 (-160; 2600)    582       7      1203 (312; 2094)     
  Total                                                         34659        30           87 (43; 130)           67236        86      128 (96; 160)        95202    140    147 (123; 171)       117366    205    175 (151; 199)       \<0.0001
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **147 (80; 269)**                           **225 (163; 310)**                   **218 (183; 261)**                    **197 (171; 226)**   **0.374**
  **Asian & Other combined**                                                                                                                                                                                                          
  15--64[\*](#t002fn002){ref-type="table-fn"}                   10059        6            60 (-8; 127)           37293        15      40 (13; 68)          119214   50     42 (30; 54)          309123    76     25 (19; 30)          
  65--74                                                        324          6            1852 (-244; 3947)      894          8       895 (-86; 1875)      4689     42     896 (625; 1167)      19515     58     297 (221; 374)       
  75--84                                                        207          4            1932 (-746; 4610)      372          5       1344 (166; 2522)     1437     21     1461 (836; 2086)     8220      40     487 (336; 637)       
  85+                                                           30           4            13333 (-5146; 31812)   108          2       1852 (-715; 4418)    327      7      2141 (555; 3727)     1971      22     1116 (650; 1583)     
  Total                                                         10620        20           188 (72; 305)          38667        30      78 (40; 115)         125667   120    95 (78; 113)         338829    196    58 (50; 66)          \<0.0001
  **Standardised** [^**§**^](#t002fn003){ref-type="table-fn"}                             **360 (185; 701)**                          **158 (92; 271)**                    **166 (137; 202)**                    **68 (59; 79)**      **\<0.0001**

N is the estimated population size and n is the number of events.

\* 16--64 in 2011--2012,

^**§**^ Age-standardised to WHO world population

Between the 1981--1982 and 2011--2012 studies there were significant increases across all ethnic groups in the proportion of patients admitted to hospital within 28 days of stroke onset (28% \[95% CI 26%-31%\]), and in patients having neuroimaging verification of stroke pathological types (84.9% \[95% CI 62.8%-100.0%\]). There were also increases in patients receiving blood pressure lowering (27.0% \[95% CI 24.0%-31.0%\])) and antiplatelet (aspirin, clopidogrel, dipyridamole: 21.0% \[95% CI 17.0%-24.0%\]) medications pre-stroke ([Table 1](#pone.0134609.t001){ref-type="table"}). However, there was a significant decrease in the proportion of stroke patients receiving anticoagulants pre-stroke from 2002--2003 to 2011--2012 (2.1% \[95% CI 0.66%-3.5%\]).

We observed that risk factors prevalence increased significantly over 30 years ([Table 1](#pone.0134609.t001){ref-type="table"}), with the proportion of patients with a history of high blood pressure (≥160/95 mmHg; including people on antihypertensive medication) increasing between the first and last survey by 15.0% (95% CI 11.7%-18.4%), myocardial infarction by 12.6% (95% CI 12.8%-15.1%), and diabetes mellitus by 12.5% (95% CI 10.1%-14.9%), across all ethnic groups except Māori for high blood pressure, myocardial infarction and Type 2 diabetes mellitus, and Asian/other people for diabetes mellitus. However, there was a statistically significant decrease in the frequency of current smokers among stroke patients by 11.9% (95% CI 9.1%-14.8%), except for Pacific people in whom the smoking rate over the last decade increased by almost two times. There was also a noticeable reduction in the proportional frequency of strokes due to SAH (2.5% \[95% CI 2.3%-2.6%\]), and a noticeable decline in 28-day stroke case-fatality of 14.8% \[95% CI 9.7%-20.0%\] from 1981--1982 in 2011--2012 across all ethnic groups. Māori and Pacific people with stroke had a greater prevalence of smoking (40.4% and 24.4%) and diabetes mellitus (29.7% and 43.3%) compared with NZ Europeans (12.8% and 16.5%, respectively), but lower prevalence of MI (18.1% and 12.6% vs 28.0%) ([Table 1](#pone.0134609.t001){ref-type="table"}).

Between 2002--2003 and 2011--2012, there were significant increases in the proportion of stroke patients identified as having atrial fibrillation (AF) (7.2% \[95% CI 2.4%-12.0%\], only significant for NZ Europeans), patients receiving lipid lowering medications (26.6% \[15.0%-38.2%\], patients admitted to acute stroke unit (37.3% \[95% CI 18.1--56.5%\]). There was a significant decrease of patients with undetermined stroke (from 11.7% to 1.9%), across all ethnic groups.

Age-standardised stroke mortality rates ([Table 3](#pone.0134609.t003){ref-type="table"}) reduced by almost 3 times between 1981--1982 and 2011--2012, declining from 98/100,000 (95% CI 88/100,000--110/100,000) person-years in 1981--1982 to 37/100,000 (95% CI 34/100,000--40/100,000) person-years in 2011--2012 (test for trend p \< 0.0001 \[which remained significant after adjustment for multiple-testing\]). Decreases in age-adjusted 1-year stroke mortality rates were seen in NZ Europeans (2% per year), Māori (1.4% per year) and Asian/other ethnic groups (7% per year) over the last 30 years. Age-adjusted stroke mortality rates (per 100,000 person-years) in Pacific people reduced from 127 (95% CI 81--198) in 1991--1992 to 124 (95% CI 96--162) in 2002--2003 and 74 (95% CI 58--95) in 2011--2012 (p for trend = 0.0002).

10.1371/journal.pone.0134609.t003

###### Crude, age-specific and age-standardised annual stroke mortality rates per 100,000 people in Auckland, New Zealand across four study periods (1981--1982, 1991--1992, 2002--2003 and 2011--2012) by sex and ethnicity.

![](pone.0134609.t003){#pone.0134609.t003g}

  Age and ethnic group                                         1981--1982   1991--1992   2002--2003             2011--2012   Trend                                                                                               
  ------------------------------------------------------------ ------------ ------------ ---------------------- ------------ ------- -------------------- -------- ----- ------------------- --------- ----- ------------------- --------------
  **Total**                                                                                                                                                                                                                      
  15--64[\*](#t003fn001){ref-type="table-fn"}                  518112       104          20 (15; 26)            624828       122     20 (16; 23)          788106   89    11 (9; 14)          956037    84    9 (7; 11)           
  65--74                                                       49812        168          337 (265; 409)         56388        136     241 (196; 287)       59454    99    167 (134; 199)      95190     90    95 (75; 114)        
  75--84                                                       22965        266          1158 (961; 1355)       31701        226     713 (615; 811)       37815    232   614 (535; 692)      48387     184   380 (325; 435)      
  85+                                                          5691         126          2214 (1667; 2761)      8541         148     1733 (1422; 2044)    12507    227   1815 (1579; 2051)   19578     237   1211 (1056; 1365)   
  Total                                                        596580       664          111 (99; 123)          721458       632     88 (80; 95)          897882   647   72 (67; 78)         1119192   595   53 (49; 57)         \<0.0001
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **98 (88; 110)**                            **72 (67; 79)**                     **57 (53; 62)**                     **37 (34; 40)**     **\<0.0001**
  **Male**                                                                                                                                                                                                                       
  15--64[\*](#t003fn001){ref-type="table-fn"}                  256500       58           23 (14; 31)            308997       61      20 (15; 25)          380139   48    13 (9; 16)          461418    36    8 (5; 10)           
  65--74                                                       22251        98           440 (317; 564)         25452        83      326 (242; 410)       28173    59    209 (156; 263)      45678     55    120 (89; 152)       
  75--84                                                       8742         100          1144 (827; 1461)       11946        102     854 (670; 1038)      15210    88    579 (458; 699)      21759     96    441 (353; 529)      
  85+                                                          1509         28           1856 (884; 2828)       2421         22      909 (529; 1288)      3633     58    1596 (1186; 2007)   6807      73    1072 (826; 1318)    
  Total                                                        289002       284          98 (82; 114)           348816       268     77 (67; 87)          427155   253   59 (52; 67)         535662    260   49 (43; 54)         \<0.0001
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **104 (88; 123)**                           **76 (67; 87)**                     **59 (52; 66)**                     **39 (35; 44)**     **\<0.0001**
  **Female**                                                                                                                                                                                                                     
  15--64[\*](#t003fn001){ref-type="table-fn"}                  261612       46           18 (10; 25)            315831       61      19 (14; 25)          407967   41    10 (7; 13)          494631    48    10 (7; 12)          
  65--74                                                       27561        70           254 (170; 338)         30936        53      171 (125; 217)       31281    40    128 (88; 168)       49509     35    71 (47; 94)         
  75--84                                                       14223        166          1187 (916; 1418)       19755        124     628 (517; 738)       22605    144   637 (533; 741)      26634     88    330 (261; 399)      
  85+                                                          4182         98           2343 (1687; 3000)      6120         126     2059 (1651; 2466)    8874     169   1904 (1617; 2192)   12771     164   1284 (1088; 1481)   
  Total                                                        307578       380          124 (106; 141)         372642       364     98 (87; 108)         470727   394   84 (75; 92)         583545    335   57 (51; 64)         \<0.0001
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **92 (79; 106)**                            **67 (60; 75)**                     **55 (50; 61)**                     **35 (32; 40)**     **\<0.0001**
  **NZ European**                                                                                                                                                                                                                
  15--64[\*](#t003fn001){ref-type="table-fn"}                  422202       76           18 (12; 24)            459267       72      16 (12; 20)          501426   44    9 (6; 11)           450759    35    8 (5; 10)           
  65--74                                                       47481        156          329 (256; 401)         52125        120     230 (183; 277)       48633    60    123 (92; 155)       64806     49    76 (54; 97)         
  75--84                                                       22209        258          1162 (961; 1362)       30303        204     673 (578; 768)       34332    193   562 (483; 641)      35916     135   376 (312; 439)      
  85+                                                          5577         122          2188 (1639; 2737)      8253         145     1757 (1437; 2076)    11790    195   1654 (1422; 1886)   16776     204   1216 (1049; 1383)   
  Total                                                        497469       612          123 (109; 137)         549948       541     98 (89; 107)         596181   492   83 (75; 90)         568257    423   74 (67; 82)         \<0.0001
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **96 (86; 107)**                            **67 (61; 74)**                     **49 (45; 54)**                     **35 (31; 39)**     **\<0.0001**
  **Māori**                                                                                                                                                                                                                      
  15--64[\*](#t003fn001){ref-type="table-fn"}                  52179        14           27 (7; 47)             63762        18      28 (15; 41)          77742    16    21 (10; 31)         88470     17    19 (10; 28)         
  65--74                                                       1266         6            474 (-62; 1010)        1344         3       223 (-29; 476)       2282     7     305 (79; 532)       4452      4     90 (2; 178)         
  75--84                                                       336          4            1190 (-459; 2840)      429          9       2098 (727; 3469)     654      5     765 (94; 1435)      1572      9     573 (198; 947)      
  85+                                                          51           0            0                      72           2       2778 (-1072; 6628)   144      2     1389 (-536; 3314)   243       3     1235 (-162; 2632)   
  Total                                                        53832        24           45 (19; 70)            65607        32      49 (32; 66)          80832    30    37 (24; 50)         94737     33    35 (23; 47)         0.203
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **96 (47; 196)**                            **133 (85; 209)**                   **77 (50; 118)**                    **53 (36; 77)**     **0.015**
  **Pacific**                                                                                                                                                                                                                    
  15--64[\*](#t003fn001){ref-type="table-fn"}                  33672        12           36 (7; 64)             64506        27      42 (26; 58)          89724    17    19 (10; 28)         107688    22    20 (12; 29)         
  65--74                                                       741          4            540 (-208; 1288)       2025         10      494 (188; 800)       3840     21    547 (313; 781)      6417      20    312 (175; 448)      
  75--84                                                       213          0            0                      597          10      1675 (135; 3215)     1392     19    1365 (751; 1979)    2679      16    597 (305; 890)      
  85+                                                          33           0            0                      108          0       0                    246      7     2846 (738; 4954)    582       10    1718 (653; 2783)    
  Total                                                        33           16           46 (14; 78)            67236        47      70 (48; 92)          95202    64    67 (51; 84)         117366    68    58 (44; 72)         0.949
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **69 (30; 160)**                            **127 (81; 198)**                   **124 (96; 162)**                   **74 (58; 95)**     **0.005**
  **Asian/other**                                                                                                                                                                                                                
  15--64[\*](#t003fn001){ref-type="table-fn"}                  10059        2            20 (-19; 59)           37293        5       13 (2; 25)           119214   11    9 (4; 15)           309123    10    3 (1; 5)            
  65--74                                                       324          2            617 (-593; 1827)       894          3       336 (-44; 715)       4689     8     171 (52; 289)       19515     16    82 (42; 122)        
  75--84                                                       207          4            1932 (-746; 4610)      372          3       806 (-106; 1719)     1437     10    696 (265; 1127)     8220      24    292 (175; 409)      
  85+                                                          30           4            13333 (-5146; 31812)   108          1       926 (-889; 2741)     327      8     2446 (751; 4142)    1971      20    1015 (570; 1459)    
  Total                                                        10620        12           113 (23; 203)          38667        12      31 (13; 49)          125667   37    29 (20; 39)         338829    70    21 (16; 25)         \<0.0001
  **Standardise** [^**§**^](#t003fn002){ref-type="table-fn"}                             **238 (102; 557)**                          **70 (37; 132)**                    **64 (45; 91)**                     **27 (21; 34)**     **\<0.0001**

\* 16--64 in 2011--2012,

^**§**^ Age-standardised to WHO world population

Over the 30-year study period, there was a 23% (95% CI 15%-31%) reduction in stroke incidence ([Fig 1](#pone.0134609.g001){ref-type="fig"}) and 27% (95% CI 21%-33%) reduction in stroke attack rate overall ([Table 4](#pone.0134609.t004){ref-type="table"} and [Fig 1](#pone.0134609.g001){ref-type="fig"}). These reductions were largely due to decreases in NZ Europeans (decrease 20% in incidence, 26% attack rates) and Asian/others (decrease 81% \[95% CI 63%-90%\] in incidence, 75% \[95% CI 51%-87%\] in attack rates) (Figs [2](#pone.0134609.g002){ref-type="fig"} and [3](#pone.0134609.g003){ref-type="fig"}). However, in Māori and Pacific people, there were non-significant increases in stroke incidence (first-ever strokes) and attack rates (incident and recurrent strokes combined) between 1981--1982 and 2011--2012 study periods. Overall, decreases in stroke incidence and attack rates were limited to people 65 years or older ([Fig 3](#pone.0134609.g003){ref-type="fig"}). In people aged 15--64 years, there were no significant changes in stroke incidence or attack rates, except for Pacific people where stroke incidence and attack rates doubled ([Fig 1](#pone.0134609.g001){ref-type="fig"}).

10.1371/journal.pone.0134609.t004

###### Crude, age-specific and age-standardised annual attack (first-ever and recurrent strokes combined) rates per 100,000 people-years in Auckland, New Zealand across four study periods (1981--1982, 1991--1992, 2002--2003 and 2011--2012) by sex and ethnicity.

![](pone.0134609.t004){#pone.0134609.t004g}

  Age, sex and ethnicity group                                  1981--1982   1991--1992   2002--2003             2011--2012   *P* value for trend                                                                                                   
  ------------------------------------------------------------- ------------ ------------ ---------------------- ------------ --------------------- -------------------- -------- ------ -------------------- --------- ------ -------------------- --------------
  **Total**                                                                                                                                                                                                                                         
  15--64[\*](#t004fn001){ref-type="table-fn"}                   518112       350          68 (58;78)             624828       433                   69 (61; 77)          788106   484    61 (56; 67)          956037    626    65 (60; 71)          
  65--74                                                        49812        380          763 (654; 871)         56388        512                   908 (795; 1021)      59454    460    774 (703; 844)       95190     476    500 (455; 545)       
  75--84                                                        22965        498          2169 (1899; 2438)      31701        611                   1927 (1730; 2125)    37815    667    1764 (1630; 1898)    48387     598    1236 (1137; 1335)    
  85+                                                           5691         178          3128 (2478; 3778)      8541         247                   2892 (2460; 3324)    12507    390    3118 (2809; 3428)    19578     448    2288 (2076; 2500)    
  Total                                                         596580       1406         236 (218; 253)         721458       1803                  250 (235; 265)       897882   2001   223 (213; 233)       1119192   2148   192 (184; 200)       \<0.0001
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **211 (196; 228)**                                        **213 (201; 227)**                   **193 (185; 202)**                    **153 (147; 160)**   **\<0.0001**
  **Male**                                                                                                                                                                                                                                          
  15--64[\*](#t004fn001){ref-type="table-fn"}                   256500       204          80 (64; 95)            308997       252                   82 (69; 94)          380139   273    72 (63; 80)          461418    323    70 (62; 78)          
  65--74                                                        22251        224          1007 (820; 1193)       25452        290                   1139 (947; 1332)     28173    273    969 (854; 1084)      45678     272    595 (525; 666)       
  75--84                                                        8742         216          2471 (2005; 2937)      11946        252                   2109 (1768; 2451)    15210    277    1821 (1607; 2036)    21759     305    1402 (1244; 1559)    
  85+                                                           1509         46           3048 (1803; 4294)      2421         41                    1694 (1175; 2212)    3633     95     2615 (2089; 3141)    6807      138    2027 (1689; 2366)    
  Total                                                         289002       690          239 (214; 264)         348816       835                   239 (218; 261)       427155   918    215 (201; 229)       535662    1038   194 (182; 206)       \<0.0001
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **248 (223; 276)**                                        **236 (216; 258)**                   **214 (200; 228)**                    **167 (157; 178)**   **\<0.0001**
  **Female**                                                                                                                                                                                                                                        
  15--64[\*](#t004fn001){ref-type="table-fn"}                   261612       146          56 (43; 69)            315831       181                   57 (47; 67)          407967   211    52 (45; 59)          494631    303    61 (54; 68)          
  65--74                                                        27561        156          566 (440; 692)         30936        222                   718 (587; 848)       31281    187    598 (512; 683)       49509     204    412 (356; 469)       
  75--84                                                        14223        282          1983 (1655; 2310)      19755        359                   1817 (1577; 2058)    22605    390    1725 (1554; 1897)    26634     293    1100 (974; 1226)     
  85+                                                           4182         132          3156 (2395; 3918)      6120         206                   3366 (2799; 3934)    8874     295    3324 (2945; 3704)    12771     310    2427 (2157; 2698)    
  Total                                                         307578       716          233 (209; 257)         372642       968                   260 (239; 281)       470727   1083   230 (216; 244)       583545    1110   190 (179; 201)       \<0.0001
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **181 (163; 201)**                                        **190 (175; 206)**                   **173 (162; 184)**                    **140 (132; 149)**   **\<0.0001**
  **NZ European**                                                                                                                                                                                                                                   
  15--64[\*](#t004fn001){ref-type="table-fn"}                   422202       276          65 (54; 76)            459267       293                   64 (55; 73)          501426   269    54 (47; 60)          450759    288    64 (57; 71)          
  65--74                                                        47481        354          746 (636; 855)         52125        459                   881 (764; 997)       48633    303    623 (553; 693)       64806     312    481 (428; 535)       
  75--84                                                        22209        488          2197 (1922; 2473)      30303        579                   1911 (1709; 2113)    34332    568    1654 (1518; 1790)    35916     470    1309 (1190; 1427)    
  85+                                                           5577         174          3120 (2464; 3776)      8253         241                   2920 (2476; 3364)    11790    345    2926 (2617; 3235)    16776     400    2384 (2151; 2618)    
  Total                                                         497469       1292         260 (240; 280)         549948       1572                  286 (267; 305)       596181   1485   249 (236; 262)       568257    1470   259 (245; 272)       0.165
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **209 (193; 226)**                                        **206 (193; 220)**                   **171 (162; 180)**                    **154 (145; 163)**   **\<0.0001**
  **Māori**                                                                                                                                                                                                                                         
  15--64[\*](#t004fn001){ref-type="table-fn"}                   52179        46           88 (52; 124)           63762        58                    91 (63; 119)         77742    60     77 (58; 97)          88470     88     99 (79; 120)         
  65--74                                                        1266         10           790 (98; 1482)         1344         8                     595 (183; 1008)      2282     24     1047 (628; 1466)     4452      25     562 (341; 782)       
  75--84                                                        336          6            1786 (-235; 3806)      429          14                    3263 (1554; 4973)    654      15     2294 (1133; 3454)    1572      24     1527 (916; 2138)     
  85+                                                           51           0            0                      72           2                     2778 (-1072; 6628)   144      5      3472 (429; 6516)     243       4      1646 (33; 3259)      
  Total                                                         53832        62           115 (75; 156)          65607        104                   129 (104; 153)       80832    104    129 (104; 153)       94737     141    149 (124; 173)       0.073
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **192 (122; 304)**                                        **254 (188; 341)**                   **247 (196; 311)**                    **192 (161; 229)**   **0.867**
  **Pacific**                                                                                                                                                                                                                                       
  15--64[\*](#t004fn001){ref-type="table-fn"}                   33672        22           65 (27; 104)           64506        65                    101 (74; 127)        89724    88     98 (78; 119)         107688    155    144 (121; 167)       
  65--74                                                        741          10           1350 (167; 2532)       2025         33                    1630 (899; 2360)     3840     67     1745 (1327; 2163)    6417      64     997 (753; 1242)      
  75--84                                                        213          0            0                      597          13                    2178 (536; 3819)     1392     39     2802 (1922; 3661)    2679      45     1680 (1189; 2171)    
  85+                                                           33           0            0                      108          2                     1852 (-715; 4418)    246      8      3252 (998; 5506)     582       15     2577 (1273; 3882)    
  Total                                                         34659        32           92 (47; 138)           67236        113                   168 (131; 205)       95202    202    212 (183; 241)       117366    279    238 (210; 266)       \<0.0001
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **152 (85; 274)**                                         **291 (220; 384)**                   **329 (284; 382)**                    **275 (244; 310)**   **0.012**
  **Asian/other**                                                                                                                                                                                                                                   
  15--64[\*](#t004fn001){ref-type="table-fn"}                   10059        6            60 (-8; 127)           37293        17                    46 (17; 74)          119214   64     54 (41; 67)          309123    95     31 (25; 37)          
  65--74                                                        324          6            1852 (-244; 3947)      894          12                    1342 (268; 2416)     4689     55     1173 (863; 1483)     19515     74     379 (293; 466)       
  75--84                                                        207          4            1932 (-746; 4610)      372          5                     1344 (166; 2522)     1437     34     2366 (406; 3161)     8220      58     706 (524; 887)       
  85+                                                           30           4            13333 (-5146; 31812)   108          2                     1852 (-715; 4418)    327      10     3058 (1163; 4954)    1971      29     1471 (936; 2007)     
  Total                                                         10620        20           188 (72; 305)          38667        36                    93 (54; 132)         125667   163    130 (110; 150)       338829    256    76 (66; 85)          \<0.0001
  **Standardised** [^**§**^](#t004fn002){ref-type="table-fn"}                             **360 (185; 701)**                                        **194 (122; 310)**                   **234 (197; 277)**                    **90 (79; 101)**     **\<0.0001**

\* 16--64 in 2011--2012,

^§^ Age-standardised to WHO world population

![Forest plot of stroke incidence and attack rate ratios (2011--2012 compared with 1981--1982), with rates age-adjusted to the WHO world population.](pone.0134609.g001){#pone.0134609.g001}

![Stroke incidence rates over 3 decades by ethnicity.](pone.0134609.g002){#pone.0134609.g002}

![Stroke incidence rates over 3 decades by 4 age groups.](pone.0134609.g003){#pone.0134609.g003}

In 2011--2012, 54% (95% CI 48%-61%) of first ever incident and 51% (95% CI 46%-57%) of recurrent strokes occurred in people younger than 75 years ([Table 2](#pone.0134609.t002){ref-type="table"}). The proportion of incident and recurrent strokes in Māori and Pacific people younger than 75 years was twice that of NZ Europeans (44% \[95% CI 40%-48%\] and 41% \[95% CI 35%-47%\] incident and recurrent stroke in NZ Europeans aged 15--74 years compared to 82% \[95% CI 74%-90%\] and 80% \[95% CI 72%-89%\] in Māori and 82% \[95% CI 73%-93%\] and 78% \[95% CI 69%-89%\] in Pacific people aged 15--74 years, respectively). The temporal trends in declining stroke incidence and attack rates were consistent in both males and females aged 65 years and older (Tables [2](#pone.0134609.t002){ref-type="table"} and [4](#pone.0134609.t004){ref-type="table"}), with the most noticeable decline observed in males (Tables [2](#pone.0134609.t002){ref-type="table"} and [4](#pone.0134609.t004){ref-type="table"}) and NZ Europeans (Tables [2](#pone.0134609.t002){ref-type="table"} and [4](#pone.0134609.t004){ref-type="table"}, [Fig 1](#pone.0134609.g001){ref-type="fig"}).

Stroke mortality rates increased with age across all study periods. In 2011--2012, there were no significant differences in age-adjusted stroke mortality rates (per 100,000 person-years) between males and females (39 \[95% CI 35--44\] and 35 \[95% CI 32--40\], respectively). In 2011--2012, age-adjusted stroke mortality rates were highest in Pacific and Māori people (74 \[95% CI 58--95\] and 53 \[95% CI 36--77\], respectively), and lowest in Asian/other and NZ/European people (27 \[95% CI 21--34\] and 35 \[95% CI 31--39\] respectively). Māori and Pacific people had a test for trend of p\<0.0001, which reflected both an increase in stroke incidence and mortality rates from 1981--1992 and a decline in stroke incidence and mortality rates from 2002--2012. All other ethnicities (NZ/Europeans, Asian/other), total, males, females all had test for trend p\<0.0001 which reflected the continuous decline in stroke incidence and mortality rates across the study period. The overall current level of stroke incidence rates in NZ remains high compared to other developed countries where comparable population-based stroke incidence studies were carried out in 2000--2014 period\[[@pone.0134609.ref026]--[@pone.0134609.ref032]\] ([Fig 4](#pone.0134609.g004){ref-type="fig"}).

![Annual age-adjusted stroke incidence rates in population-based studies\[[@pone.0134609.ref014],[@pone.0134609.ref026]--[@pone.0134609.ref032],[@pone.0134609.ref048]--[@pone.0134609.ref051]\] carried out in high-income countries in 2000--2014.](pone.0134609.g004){#pone.0134609.g004}

Discussion {#sec011}
==========

The main findings of this study include: (a) a clear trend towards reducing stroke incidence, 28-day case-fatality and 1-year mortality rates; (b) an increase in the frequency of elevated blood pressure, myocardial infarction, Type 2 diabetes mellitus and AF among stroke patients, but decrease in the frequency of current smoking; (c) better survival of acute stroke patients across all ethnic groups; and (d) persistent differences in stroke incidence, mortality rates and risk factor prevalence across the four major ethnic groups in NZ. Overall, the ethnic disparities have lessened overtime, especially over the last study decade. Our findings of decrease in stroke incidence and mortality rates overall in the study population but an increase, although not significant, in stroke rates in people younger than 64 years old (particularly females, Māori and Pacific Island people) are concordant with those of the GBD 2010 Study which identified a continuous decline in stroke incidence and mortality rates in high-income countries,\[[@pone.0134609.ref001]\] and a trend towards a stable or increasing stroke burden in people younger than 65 years.\[[@pone.0134609.ref001]\] The latter is of particular concern as our data showed an increased frequency of several major vascular risk factors in people with stroke that was also observed in the general NZ population and other countries.\[[@pone.0134609.ref014],[@pone.0134609.ref033]--[@pone.0134609.ref035]\] This includes an epidemic of obesity and Type 2 diabetes mellitus in children and young adults,\[[@pone.0134609.ref036],[@pone.0134609.ref037]\] as well as behavioural and dietary risk factors.\[[@pone.0134609.ref038]--[@pone.0134609.ref040]\] An increase (or no reduction) in the incidence of stroke in middle-age populations has been observed in other studies,\[[@pone.0134609.ref041],[@pone.0134609.ref042]\] thus re-emphasising the need for intensification of appropriate primary stroke prevention strategies, especially on at a population level.

Although the overall decline in stroke incidence rates is in line with some population-based studies,\[[@pone.0134609.ref043]--[@pone.0134609.ref047]\] the decline in stroke incidence in NZ over the last 30 years is almost 20% less than that of comparable studies for a similar study period ([Fig 4](#pone.0134609.g004){ref-type="fig"}).\[[@pone.0134609.ref013],[@pone.0134609.ref014],[@pone.0134609.ref026]--[@pone.0134609.ref032],[@pone.0134609.ref048]--[@pone.0134609.ref051]\] Further, this study has highlighted that the relatively high level of stroke incidence in NZ is largely attributed to high rates in Māori and Pacific people. Moreover, unlike similar studies,\[[@pone.0134609.ref014],[@pone.0134609.ref030],[@pone.0134609.ref044]\] we found a significant trend towards increase in the prevalence of elevated blood pressure, history of myocardial infarction and diabetes mellitus among stroke patients and this may be a contributing factor to the observed differences in NZ compared to other high-income countries. Indeed, the 2008/2009 NZ Adult Nutrition Survey showed that there was an increase in mean systolic blood pressure in the overall population since 2002, but in particular in Māori men aged 35--74. The prevalence of hypertension in the NZ population in 2008/2009 was estimated at 31%, with only 15% on anti-hypertensive medication.\[[@pone.0134609.ref039]\] However, the increasing prevalence of elevated blood pressure, MI and Type 2 diabetes in stroke patients may also be related to increased detection of undiagnosed hypertension, diabetes and other health conditions over the study period, therefore these data should be interpreted with caution. The proportion of recurrent strokes has shown a statistically significant decrease over the study period overall and NZ European and Maori people in particularly, although the level of recurrent strokes (21.4%) in NZ remains relatively high compared to some other developed countries.\[[@pone.0134609.ref052]\] There was no statistically significantly change in the proportion of recurrent strokes in Pacific, Asian and other ethnic groups in NZ from 1981 to 2012 and but showed a trend towards increasing. This and the overall high rate of recurrent strokes in NZ (especially in Maori and Pacific people younger than 75 years) signify the need for better, culturally appropriate secondary stroke prevention strategies.

The younger age of stroke onset in Māori is also reflected in the lower life expectancy at birth of Māori, which in 2006 was at least eight years less than that for non-Māori for both genders.\[[@pone.0134609.ref053]\] Of note is the increase in the prevalence of atrial fibrillation and low levels of pre-morbid anticoagulation of patients with AF over the last decade. Despite 36.1% of ischaemic stroke patients having AF in the 2011--2012 study, only 26.5% of these patients were being treated with anticoagulation therapy prior to stroke. A similar increase in the prevalence of AF in stroke patients was recently observed in another population-based study.\[[@pone.0134609.ref054]\] This, together with the global epidemic of AF,\[[@pone.0134609.ref055]\] suggests that it is now becoming the leading risk factor for stroke.

Similar diverging trends and ethnic disparities in stroke incidence have been shown in other comparable population-based studies in the US\[[@pone.0134609.ref043]\] and UK,\[[@pone.0134609.ref044]\] suggesting unfavorable trends in the prevalence of risk factors.\[[@pone.0134609.ref056]\] In the Atherosclerosis Risk in Communities cohort there was a 40% increase in the proportion of hypertension and diabetes from 1987 to 2011.\[[@pone.0134609.ref046]\] Ethnic differences in stroke risk have been attributed to differences in socioeconomic status (SES) and exposure to risk factors.\[[@pone.0134609.ref057]\] Lower SES groups have greater exposure to cardiovascular risk factors, including hypertension, smoking, poor diet, physical inactivity, diabetes and excess alcohol use.\[[@pone.0134609.ref058]\] Also, lower SES groups may have limited access to, or make less effective use of, services to manage these risk factors (e.g., early hypertension detection and control).\[[@pone.0134609.ref059]\] However, there is evidence that not all differences among ethnic groups are explained by differences in cardiovascular risk factors, suggesting genetic\[[@pone.0134609.ref060]\] and other factors such as socioeconomic disparities and the experience of discrimination\[[@pone.0134609.ref061]\] may be important. There remains uncertainty about the relative importance of stroke risk factor management and other factors in causing these inequalities. The impact of SES, changing family dynamics and cultural values on stroke risk and recovery in Māori and Pacific Island people is uncertain.\[[@pone.0134609.ref062]\] Ethnic-specific differences in stroke risk factors have also been shown in some other multi-ethnic populations\[[@pone.0134609.ref063]--[@pone.0134609.ref070]\] suggesting the need for culturally tailored primary and secondary preventative strategies.

If the current temporal trend in the distribution of stroke risk factors in the population continues, we are likely to observe an increase in the incidence of stroke in the near future. Primary stroke prevention is a mainstream strategy to reduce stroke burden in a population.\[[@pone.0134609.ref071]--[@pone.0134609.ref073]\] However, the relative significance of various determinants of stroke occurrence as well as cultural appropriateness of stroke prevention strategies, especially among Māori and Pacific people,\[[@pone.0134609.ref003]\] are not known, hindering the development of effective, evidence-based primary stroke prevention strategies on both individual and population levels.\[[@pone.0134609.ref004],[@pone.0134609.ref074]--[@pone.0134609.ref079]\] Furthermore, a detailed analysis of recent changes in stroke risk factors is needed to explain the diverging trends in stroke incidence and mortality rates in the different ethnic groups in NZ and to further inform culturally appropriate primary stroke prevention strategies.\[[@pone.0134609.ref080]\]

Better management (including enhanced admission rates to acute stroke units) and resulting improved 28-day and 1-year survival of acute stroke patients have been observed in other studies.\[[@pone.0134609.ref013],[@pone.0134609.ref032],[@pone.0134609.ref081],[@pone.0134609.ref082]\] Although hospital admission has improved in this study over the 30 year period, there is still an underutilisation of acute stroke units (only 51% of stroke patients were treated in acute stroke units) and thrombolytic therapy for ischaemic stroke patients (only 5% of ischaemic stroke patients received alteplase \[data not shown\]) against the recommended corresponding figures in the NZ guidelines.\[[@pone.0134609.ref083]\] A recent individual-participant data meta-analysis of alteplase\[[@pone.0134609.ref084]\] demonstrated that irrespective of age or stroke severity, and despite an increased risk of fatal intracranial haemorrhage during the first few days after treatment, alteplase significantly improves the overall odds of a good stroke outcome when delivered within 4·5 h of stroke onset, with earlier treatment associated with bigger proportional benefits. Similar to some previous observations\[[@pone.0134609.ref085],[@pone.0134609.ref086]\] but contrary to others\[[@pone.0134609.ref087]--[@pone.0134609.ref089]\] we found a moderate, though non-statistically significant, decrease in the incidence of subarachnoid haemorrhage that may be related to the reduced smoking rates\[[@pone.0134609.ref090]\] in NZ.\[[@pone.0134609.ref091]\]

The observed level and magnitude in stroke mortality decline in Auckland, NZ (3-fold decline \[from 98/100,000 person-years in 1981--1982 to 37/100,000 person-years in 2011--2012\]) is similar to official NZ statistics on stroke mortality rates,\[[@pone.0134609.ref092]\] supporting the validity of our data. However, our findings of faster declines in stroke mortality rates than stroke incidence rates, in line with our previous estimates,\[[@pone.0134609.ref093]\] suggest a further rise of stroke related disability over the next decade due to population growth and aging in NZ. This is of particular importance for Māori and Pacific groups where there has been a substantial increase in stroke in younger age groups, thus emphasizing the importance and priority of primary stroke prevention. A mismatch in temporal trends between stroke incidence and mortality rates has been shown in some other populations.\[[@pone.0134609.ref094]\]

Novelty and Translation {#sec012}
-----------------------

To the best of our knowledge, this is the first, longest and largest population-based survey to compare long-term trends and 1-year outcomes of stroke. There are several important new findings reported in this paper. The first is the diverging and changing trends in stroke incidence and stroke risk factors in different ethnic groups of the population. The trends in stroke incidence for Māori and Pacific Island people behave are similar to those observed in low to middle-income countries, while in NZ/ Europeans, trends in stroke incidence are like those in high-income countries with ethnically more homogeneous populations. Ethnicity/race is a proxy for disparity\[[@pone.0134609.ref095]\] and this is relevant internationally because other ethnically diverse societies will need to make provisions for population sub-groups prone to disparity to ensure that they have access to appropriate health care. Second, our findings were obtained before and during contemporary changes in prevention (primary and secondary) and service delivery (acute stroke unit care and thrombolysis) in a whole population context. This provides, for the first time, direct feedback to health-policy decision-makers on the relative success of these changes in medical practice. Specifically, the study demonstrated that current stroke preventative and management strategies are far more effective in reducing stroke risk and mortality on a population level than those used before mid-1990s. This should encourage health systems worldwide to seriously consider implementing modern stroke preventive and treatment strategies if they have not already done so. Third, this is the first documentation, to the best of our knowledge, of stroke mortality rates falling faster than stroke incidence rates. If this trend is also borne out in other populations then health systems will need to adapt in order to accommodate the likely increase in rehabilitation services needs in order to cater for this increase in prevalence and, therefore, make plans to implement more effective and culturally appropriate primary stroke prevention strategies at a population level. The differences in the stroke incidence trends by ethnicity are also important to take into account when projecting stroke burden in multi-ethnic communities on a national and global scale (including Global Burden of Disease estimates) and further reinforce the need for culturally appropriate prevention and health care strategies in multi-ethnic communities. The diverging trends in stroke incidence in the different ethnic groups and different rates of reduction in stroke mortality and incidence rates should be generalizable to other ethnically diverse health-care systems that have achieved similar risk factor modification.

Strength and limitations {#sec013}
------------------------

The strength of our study is that it includes four large prospective population-based stroke registers (5400 stroke patients; 3,335,112 person-years of observation) across a long timespan (over 30 years: 1981--2012). The major limitation of the study was a relatively low number of strokes in some ethnic groups, especially in the Asian/other ethnic group making it difficult to determine whether trends in incidence, attack and mortality rates were statistically significant. Although the numbers were small, one possible explanation for the apparent large reduction in stroke incidence and mortality rates in Asian/other ethnic group may be related to the large influx of younger, presumably generally healthy, Asian immigrants in NZ that has been particularly marked over the last two decades.\[[@pone.0134609.ref021]\] The NZ Health and Disability sector uses the NZ Health Statistics definition for ethnicity 'as a social construct of group affiliation and identity' where ''ethnicity is the ethnic group or groups that people identify with or feel they belong to'.\[[@pone.0134609.ref096]\] In the 1981--1982 and 2002--2003 studies, only one ethnicity was collected for participants in each study, preventing us from applying prioritised ethnicity classification in these studies. Although this may have introduced a classification bias by ethnicity, we believe the effect of the bias was not large and was likely to be non-differential as most of the ethnic priority classifications in the 1991--1992 and 2011--2012 studies were also based on the first ethnicity self-identified by the study participants. In addition, less than 10% of the last surveys study participants indicated more than one ethnicity. We lacked statistical power to stratify our analyses by ethnicity to generate specific ethnicity-covariate estimates for risk of stroke onset due to having small numbers of stroke patients per ethnic minority, particularly the Asian subgroup. Given the continuous population increase in Auckland and in New Zealand in general, it is likely that we will have improved statistical power to investigate ethnicity-covariate interactions in a future ARCOS study. Another limitation of our series of studies is that the first two ARCOS studies (1981--1982 and 1991--1992) used a cluster sampling scheme approach for case-ascertainment\[[@pone.0134609.ref097]\] and, therefore, may have underestimated the number of stroke cases in these study periods. Although we applied the same criteria for cardiovascular risk factors recorded across all studies, we acknowledge that the accuracy of information about these risk factors was prone to some degree of variation and, therefore, should be interpreted with caution. However, the consistency of the assessment procedures, diagnostic criteria, the implementation of quality control procedures during the four studies, together with the decreased estimated number of missing stroke cases (as determined by capture-recapture analyses), reassure us that case-ascertainment was high across all these studies. Finally, due to the lack of reliable verification of pathological types of stroke in the 1981--1982 and 1991--1992 studies, analysis of changes in pathological types of stroke was limited to the 2002--2003 and 2011--2012 ARCOS studies. The larger proportion of ischaemic strokes in 2011--2012 compared to 2002--2003 may be related to a greater use of brain scanning (97% in 2011--2012; 88% in 2002--2003) which shifted classification of some strokes as 'undetermined' to the ischaemic group.

Conclusions {#sec014}
===========

A continuous and recently accelerated reduction in total stroke incidence and mortality has been found over the last three decades in the Auckland region of NZ. Despite a trend towards closing the gap in reducing the difference in stroke burden between NZ European and non-European ethnic groups in NZ, the 15-year differences in the mean age of stroke onset in Māori and Pacific compared to NZ/ Europeans has persisted. Some positive changes in the profile of risk factors in people with stroke, such as overall decline in the proportion of current smokers and recurrent strokes, and increased use of antiplatelet, blood pressure and lipid lowering medications, were counterbalanced by increasing prevalence of high blood pressure, myocardial infarction, diabetes mellitus, AF, and low use of anticoagulants in people with AF. This, together with the ongoing discordance between trends in stroke incidence and mortality rates and persistent ethnic disparities in stroke burden, emphasises the need for better understanding of causes of ethnic disparities in stroke burden. Culturally appropriate primary stroke prevention strategies need to be prioritised at a population level.\[[@pone.0134609.ref098]\] Some of these strategies need government intervention in terms of increases in taxes on cigarettes and alcohol for example, reduction in the levels of salt and sugar in the population,\[[@pone.0134609.ref099],[@pone.0134609.ref100]\] the use of advertising campaigns informed by behavioural change methods to reduce smoking, alcohol, increase physical activity, or evidence-based interventions. Government led health interventions should include stroke programmes ideally already at the school age in the regular teaching plan among other health education programs. To inform future stroke prevention strategies and reduce stroke burden, a better understanding (including modelling)\[[@pone.0134609.ref101]\] of the interplay between trends in stroke (and stroke sub-types) risk factors, demographic (e.g., aging of the population, ethnic/racial disparities) and health care (e.g., introduction of acute stroke units, thrombolysis for ischaemic stroke), morbidity (e.g. incidence and disability) and mortality rate changes in different populations is required.
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